Guggenheim Capital’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.99M Buy
52,246
+15,381
+42% +$1.48M 0.03% 447
2026
Q1
$3.82M Buy
36,865
+12,860
+54% +$1.46M 0.03% 509
2025
Q4
$2.42M Sell
24,005
-2,224
-8% -$241K 0.02% 616
2025
Q3
$3.23M Buy
26,229
+6,642
+34% +$824K 0.02% 555
2025
Q2
$2.35M Buy
19,587
+280
+1% +$37.4K 0.02% 613
2025
Q1
$2.84M Sell
19,307
-16,020
-45% -$2.45M 0.03% 549
2024
Q4
$5.74M Buy
35,327
+834
+2% +$136K 0.05% 387
2024
Q3
$5.62M Buy
34,493
+4,519
+15% +$670K 0.04% 492
2024
Q2
$4.09M Sell
29,974
-2,453
-8% -$341K 0.03% 578
2024
Q1
$4.96M Sell
32,427
-12,430
-28% -$1.86M 0.04% 559
2023
Q4
$6.4M Buy
44,857
+12,243
+38% +$1.63M 0.05% 455
2023
Q3
$4.27M Sell
32,614
-14,301
-30% -$2.17M 0.04% 541
2023
Q2
$7.46M Sell
46,915
-4,243
-8% -$684K 0.06% 390
2023
Q1
$8.1M Sell
51,158
-18,619
-27% -$2.79M 0.07% 344
2022
Q4
$9.79M Sell
69,777
-8,303
-11% -$1.18M 0.09% 292
2022
Q3
$10M Sell
78,080
-6,372
-8% -$919K 0.09% 272
2022
Q2
$11.9M Sell
84,452
-1,995
-2% -$285K 0.09% 252
2022
Q1
$12M Sell
86,447
-2,211
-2% -$339K 0.07% 335
2021
Q4
$15.5M Sell
88,658
-28,186
-24% -$4.7M 0.08% 270
2021
Q3
$19.4M Sell
116,844
-19,164
-14% -$3.3M 0.12% 183
2021
Q2
$24.5M Sell
136,008
-23,388
-15% -$4.27M 0.14% 137
2021
Q1
$30.7M Sell
159,396
-9,825
-6% -$1.89M 0.2% 90
2020
Q4
$34.2M Sell
169,221
-6,104
-3% -$1.26M 0.21% 77
2020
Q3
$36.8M Sell
175,325
-17,353
-9% -$3.86M 0.27% 62
2020
Q2
$42.3M Sell
192,678
-2,284
-1% -$456K 0.33% 51
2020
Q1
$33.8M Sell
194,962
-11,325
-5% -$1.87M 0.34% 47
2019
Q4
$31.7M Buy
206,287
+20,847
+11% +$3.12M 0.24% 79
2019
Q3
$28.2M Sell
185,440
-6,265
-3% -$990K 0.23% 84
2019
Q2
$29.4M Buy
191,705
+22,613
+13% +$3.45M 0.24% 73
2019
Q1
$27.1M Buy
169,092
+9,812
+6% +$1.52M 0.22% 77
2018
Q4
$24.6M Buy
159,280
+469
+0.3% +$73.1K 0.21% 75
2018
Q3
$23.9M Sell
158,811
-8,423
-5% -$1.2M 0.16% 109
2018
Q2
$22.6M Sell
167,234
-358,653
-68% -$44.3M 0.15% 114
2018
Q1
$70M Buy
525,887
+56,260
+12% +$7.56M 0.17% 133
2017
Q4
$69.9M Sell
469,627
-3,800
-0.8% -$517K 0.17% 160
2017
Q3
$62.5M Sell
473,427
-7,287
-2% -$979K 0.15% 171
2017
Q2
$64M Buy
480,714
+4,720
+1% +$637K 0.17% 154
2017
Q1
$64.2M Sell
475,994
-70,093
-13% -$9.08M 0.17% 129
2016
Q4
$65.5M Buy
546,087
+6,741
+1% +$795K 0.19% 94
2016
Q3
$67.5M Sell
539,346
-12,575
-2% -$1.65M 0.21% 61
2016
Q2
$76.4M Buy
551,921
+12,490
+2% +$1.62M 0.24% 54
2016
Q1
$68M Buy
539,431
+31,122
+6% +$3.96M 0.21% 70
2015
Q4
$64.5M Buy
508,309
+68,431
+16% +$8.49M 0.19% 94
2015
Q3
$50.8M Sell
439,878
-52,237
-11% -$5.86M 0.16% 140
2015
Q2
$51.2M Buy
492,115
+9,277
+2% +$1M 0.13% 211
2015
Q1
$53.3M Buy
482,838
+39,229
+9% +$4.26M 0.13% 205
2014
Q4
$46.2M Sell
443,609
-129,519
-23% -$13M 0.12% 274
2014
Q3
$55M Buy
573,128
+22,211
+4% +$2.01M 0.13% 175
2014
Q2
$50.4M Buy
550,917
+228,264
+71% +$20.4M 0.13% 185
2014
Q1
$28.4M Sell
322,653
-35,289
-10% -$3.1M 0.08% 416
2013
Q4
$33.2M Buy
357,942
+124,506
+53% +$11.2M 0.1% 274
2013
Q3
$19.1M Buy
233,436
+31,465
+16% +$2.66M 0.07% 476
2013
Q2
$16.8M Buy
+201,971
New +$17.4M 0.07% 437

Other funds holding CLX

Guggenheim Capital's CLX Position: Q2 2026 in Review

Guggenheim Capital increased its Clorox (CLX) stake by 42% in Q2 2026, buying an estimated $1.48M and bringing the position to 52,246 shares worth $4.99M. The position accounts for 0.03% of the portfolio, ranked #447.

Guggenheim Capital first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $76.4M in Q2 2016. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Guggenheim Capital held 52,246 shares of Clorox worth $4.99M as of Q2 2026.
  • Guggenheim Capital bought 15,381 Clorox shares in Q2 2026, an estimated $1.48M.
  • Clorox made up 0.03% of Guggenheim Capital's portfolio in Q2 2026, its #447 holding.
  • Guggenheim Capital first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's Clorox position peaked at $76.4M in Q2 2016.
  • 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.